Hans-Peter Albert Ostler

Mr. Hans-Peter Albert Ostler is a Chairman at Ectin Research AB, a Chairman at Alligator Bioscience AB, a Chairman at Improve Tec Hönö AB, a Chairman at Larkberget AB, a Chairman at Vakona AB, a Deputy Director at O Mgmt AB and a Wealth Manager at Söderberg & Partners Holding AB. He is on the Board of Directors at Opsy Holding AB, Hoodin AB, Ancoria Insurance Ltd., ENCare AB, Entreprenörskapital i Sverige AB, Inorbit Therapeutics AB, Lennart ekerholms stiftelse, Oblique Therapeutics AB, RGNT Electric AB and SP HMSO Göteborg AB. Mr. Ostler was previously employed as an Independent Director by Promore Pharma AB, an Independent Director by IRLAB Therapeutics AB, and a Chief Executive Officer by TikoMed AB. He received his undergraduate degree from Handelshögskolan i Göteborg and a graduate degree from Handelshögskolan i Göteborg.